PharmiWeb.com - Global Pharma News & Resources
08-Dec-2020

Flow cytometry market size and share is projected to reach US$ 9.3 Billion at a 10.2% CAGR by 2027 | COHERENT MARKET INSIGHTS

Flow cytometry is an instrument broadly used for cell counting, cell sorting, biomarker detection, and protein engineering. The process is carried out by suspending cells in a stream of fluid and passing them into an electronic detection apparatus. Flow cytometry process is broadly used in the diagnosis of various diseases such as blood cancers with several applications in basic research, clinical practice, and clinical trials. Moreover, flow cytometry also offer the study of the expression of cell surface and intracellular molecules and characterization of various cell types in a heterogeneous cell population. Furthermore, it also allows for simultaneous multi-parameter analysis of single cells. The market growth of this market primarily depends on the increasing introduction of advanced technologies, rising research activities in the life science field and increasing application of flow cytometry in the detection of HIV and cancers.

Get FREE Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-sample/1152

Recently this technology has undergone new developments with the availability of robust photodetectors and new laser emitters, lED lamps as emitter, and changes in analytical capacity. In addition to this, the introduction of advancement in flow cytometry for routine laboratory procedures, such as imaging, which acquires images of cells possible in real-time as they pass by the interrogation point are some of the major advancements in flow cytometry. This process is also used in cytology, hematology, immunology, and microbiology, among other research fields.

On the other hand, the dearth of skilled technicians for managing such advanced technology is expected to restrain the market growth.

The global flow cytometry market was valued at US$ 3.2 Bn in 2016 and is expected to witness a robust CAGR of 10.2 % over the forecast period (2017-2025).

Figure 1. Global Flow Cytometry Market Value (US$ Mn), by Region, 2018

Source: Coherent Market Insights Analysis (2020)

LIMITED TIME OFFER – Hurry Up!
Get Discount For Buyers UPTO 25% OFF On Any Research Report
Apply Promo Code “CHRISTMAS2020” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/1152

Rising clinical applications of flow cytometry are projected to favor the flow cytometry market

The increasing application of flow cytometry in the clinical laboratory for various research purposes such as immunophenotyping, cell sorting, cell cycle analysis, apoptosis, cell proliferation assays, and intracellular calcium flux is expected to favor the growth of flow cytometry market. Moreover, flow cytometry has a unique ability to determine large cell populations at the single-cell level is expected to raise the adoption of flow cytometry.

Furthermore, flow cytometry is also gaining traction in drug discovery and development, which helps to transform every stage of preclinical and clinical development, that guide new product evaluation, selection, and monitoring. Moreover, flow cytometry increases the probability of success in drug development and also offer for more informed decision making. The demand for flow cytometry is growing at all phases of development from early to late which is expected to favor the growth of flow cytometry use in industry for the drug development process.

Flow cytometry is also widely used in the testing of CD4 count for treating HIV patients with suitable antiretroviral drugs. The BD Biosciences provides CD4 testing facilities and products. BD Biosciences has 3 different systems, namely, BD FACSCount system, mostly used in emerging economies, owing to its ease of use; the BD FACSCalibur system is used in large-volume labs where over 1,000,000 tests are performed annually, and the BD FACSCanto II system, used for HIV monitoring and other applications. North America dominates the global flow cytometry market

Figure 2. Global Flow Cytometry Market Share (%), by Technology,2019 and 2027

Source: Coherent Market Insights Analysis (2020)

Read Press Release: https://www.coherentmarketinsights.com/press-release/flow-cytometry-market-to-surpass-us-764-billion-threshold-by-2025-526

North America held leding position in the global flow cytometry market, followed by Europe and this can be attributed to growing research and advancement in technology and rapid acceptance of the flow cytometry and growth of the life sciences sector in developed countries such as the U.S. Asia Pacific flow cytometry market is projected to show a high growth rate owing to the increasing prevalence of HIV. According to Joint United Nations Programme on HIV/AIDS (UNAIDS), 2016, around 49,00,000 HIV infected people aged 15 years and above were living in the Asia Pacific region, which in turn is expected to propel the market growth in the Asia Pacific region.

Some major players operating in the flow cytometry market are Becton Dickinson and Company, General Electric Company, Luminex Corporation, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Miltenyi Biotec GmbH, Merck & Co Inc., Sysmex Corporation, Agilent Technologies, Inc. and Danaher Corporation.

Detailed Segmentation:

  • Global Flow Cytometry Market, By Technology:
    • Cell-Based
    • Bead-Based
  • Global Flow Cytometry Market, By Product Type:
    • Analyzer
    • Sorter
    • Reagents & Consumables
  • Global Flow Cytometry Market, By Application:
    • Research
    • Clinical
    • Industrial
  • Global Flow Cytometry Market, By End User:
    • Hospital
    • Clinical Testing Laboratories
    • Research laboratories
  • Global Flow Cytometry Market, By Region:
    • North America
      • By Technology:
        • Cell-Based
        • Bead Based
      • By Product Type:
        • Analyzer
        • Sorter
        • Reagents & Consumables
      • By Application:
        • Research
        • Clinical
        • Industrial
      • By End User:
        • Hospital
        • Clinical Testing Laboratories
        • Research laboratories
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Technology:
      • By Product Type:
      • By Application:
      • By End User:
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Technology:
      • By Product Type:
      • By Application:
      • By End User:
      • By Country:
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Technology:
      • By Product Type:
      • By Application:
      • By End User:
      • By Country:
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • By Technology:
      • By Product Type:
      • By Application:
      • By End User:
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Technology:
      • By Product Type:
      • By Application:
      • By End User:
      • By Country/Region:
        • North Africa
        • Central Africa
        • South Africa

Other Related Reports:

Respiratory Syncytial Virus Diagnostics Market by Diagnostic Technique End User, and by Geography – Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

Immuno Oncology Assays Market by Product Type, By Technology, By Indication, and by Region -Size, Share, Outlook, and Opportunity Analysis, 2019 – 2027

Sepsis Diagnostic Market By Product, By Pathogen, By Method, By Diagnostic Method, By End User – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at contact@cdnnewswire.com.

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 08-Dec-2020